Prof Dr Laurent Servais
Laurent graduated from Louvain Medical School, Brussels in 1999, completing a PhD in Neuroscience from Free University of Brussels, Belgium followed by residences in child neurology at the Free University of Brussels and Robert Debré Hospital, Paris.
In 2008 he took a position in neuromuscular disease and clinical research at the institute of Myology in Paris where his interests and expertise in neuromuscular diseases flourished. He was subsequently appointed Head of Clinical Trials and Database Services. Most recently, he served as Head of the Institute of Myology’s I-Motion (Institute of Muscle-Oriented Translational Innovation) that he co-founded, and Head of the Neuromuscular Centre in Liège, Belgium.
Laurent joined the MDUK Oxford Neuromuscular Centre and the University of Oxford in 2019. He has been involved as a principal investigator in numerous clinical trials to test treatments for Duchenne muscular dystrophy, X-Myotubular Myopathy, Facio-scapulo humeral dystrophy and spinal muscular atrophy (SMA).
He is the leader of the newborn screening programme in southern Belgium where they are conducting a medico-economic analysis of newborn screening. Laurent also leads the Newborn Screening for SMA group initiative in the UK.
Laurent’s main research expertise covers the development of innovative outcome measures, including connected devices for real-life patients’ evaluation.